OGN
Organon & Co
Organon & Co historical holders
total: 6
Kahn Brothers Group Organon & Co transactions over time
- Total transactions:
- 20
- New positions:
- 1
- Added:
- 9
- Reduced:
- 10
- Held since:
- 2021 Q2
- Held for:
- 20 quarters
- Latest activity:
- 2026 Q1
Kahn Brothers Group has been an institutional investor in Organon & Co (OGN) since 2021 Q2. According to 2026 Q1 report, Kahn Brothers Group holds 5,536,993 shares with a market value of roughly $33.17M representing 5.88% of their equity portfolio. The fund/company first acquired OGN in 2021 Q2, initially purchasing 71,622 shares. Since the initial investment, Kahn Brothers Group has made 19 more transactions in this position.
Does Kahn Brothers Group still hold OGN?
Yes, Kahn Brothers Group continues to hold Organon & Co (OGN). According to their 2026 Q1 report, they maintain a position of 5,536,993 shares valued at approximately $33.17M, representing 5.88% of their equity portfolio.
When did Kahn Brothers Group first invest in OGN?
Kahn Brothers Group first invested in Organon & Co (OGN) in 2021 Q2 at the reported quarter-end price of $30.26 per share, acquiring 71,622 shares in their initial purchase.
What is Kahn Brothers Group's average cost basis for OGN?
Based on historical transaction data, Kahn Brothers Group's estimated cost basis for Organon & Co (OGN) is approximately $12.55 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $12.55
- Weighted AVG sell price:
- $15.44
OGN transactions history by Kahn Brothers Group
20 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
5.88%
|
5,536,993
|
$5.99
|
$33,166,588
|
+52.56% (+1,907,542)
|
+2.03%
|
|
2025 Q4
|
4.61%
|
3,629,451
|
$7.17
|
$26,023,163
|
+0.35% (+12,606)
|
+0.02%
|
|
2025 Q3
|
7.26%
|
3,616,845
|
$10.68
|
$38,627,904
|
+3.63% (+126,695)
|
+0.25%
|
|
2025 Q2
|
6.78%
|
3,490,150
|
$9.68
|
$33,784,652
|
+39.98% (+996,766)
|
+1.94%
|
|
2025 Q1
|
7.51%
|
2,493,384
|
$14.89
|
$37,126,423
|
+59.09% (+926,111)
|
+2.79%
|
|
2024 Q4
|
5.08%
|
1,567,273
|
$14.92
|
$23,383,367
|
-14.60% (-267,920)
|
-0.69%
|
|
2024 Q3
|
6.05%
|
1,835,193
|
$19.13
|
$35,107,592
|
+10.49% (+174,170)
|
+0.57%
|
|
2024 Q2
|
5.78%
|
1,661,023
|
$20.70
|
$34,382,763
|
+40.74% (+480,819)
|
+1.67%
|
|
2024 Q1
|
3.29%
|
1,180,204
|
$18.80
|
$22,187,575
|
+3,242.41% (+1,144,894)
|
+3.19%
|
|
2023 Q4
|
0.08%
|
35,310
|
$14.42
|
$509,168
|
-31.23% (-16,036)
|
-0.04%
|
|
2023 Q3
|
0.14%
|
$17.37
|
-14.13% (-8,452)
|
|||
|
2023 Q2
|
0.18%
|
$20.80
|
-2.96% (-1,821)
|
|||
|
2023 Q1
|
0.21%
|
$23.51
|
-1.62% (-1,015)
|
|||
|
2022 Q4
|
0.23%
|
$27.92
|
+0.59% (+366)
|
|||
|
2022 Q3
|
0.23%
|
$23.41
|
-6.45% (-4,290)
|
|||
|
2022 Q2
|
0.30%
|
$33.75
|
-1.26% (-846)
|
|||
|
2022 Q1
|
0.30%
|
$34.94
|
-2.13% (-1,466)
|
|||
|
2021 Q4
|
0.29%
|
$30.45
|
-1.84% (-1,294)
|
|||
|
2021 Q3
|
0.32%
|
$32.79
|
-2.04% (-1,458)
|
|||
|
2021 Q2
|
0.31%
|
$30.26
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.